The assessment and management of head injury algorithm is amended in line with this recent JRCALC update: ‘Following the results of the CRASH 3 trial, Tranexamic Acid should be administered to any patient aged 18 years and over who has a known or suspected head injury, with a GCS of 12 or less, where the injury has occurred within the last 3 hours.’
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.